These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1828434)

  • 1. Postsynaptic localization of 5-HT1D receptor binding sites in human caudate.
    Gonzalez-Heydrich J; Peroutka SJ
    Exp Neurol; 1991 Jul; 113(1):28-30. PubMed ID: 1828434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin 5-HT1D receptors in human prefrontal cortex and caudate: interaction with a GTP binding protein.
    Herrick-Davis K; Titeler M; Leonhardt S; Struble R; Price D
    J Neurochem; 1988 Dec; 51(6):1906-12. PubMed ID: 3141589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a [3H]-5-hydroxytryptamine binding site in rabbit caudate nucleus that differs from the 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D subtypes.
    Xiong WC; Nelson DL
    Life Sci; 1989; 45(16):1433-42. PubMed ID: 2811600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of 5-hydroxytryptamine1D binding sites in human brain membranes.
    Peroutka SJ; Switzer JA; Hamik A
    Synapse; 1989; 3(1):61-6. PubMed ID: 2521959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential modulation of 5-hydroxytryptamine1D binding sites by GTP and GTPgammaS.
    Harrington MA; Peroutka SJ
    Brain Res; 1990 Jan; 506(1):172-4. PubMed ID: 2405953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases.
    Reynolds GP; Mason SL; Meldrum A; De Keczer S; Parnes H; Eglen RM; Wong EH
    Br J Pharmacol; 1995 Mar; 114(5):993-8. PubMed ID: 7780656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative autoradiography of 5-HT1D and 5-HT1E binding sites labelled by [3H]5-HT, in frontal cortex and the hippocampal region of the human brain.
    Barone P; Jordan D; Atger F; Kopp N; Fillion G
    Brain Res; 1994 Feb; 638(1-2):85-94. PubMed ID: 8199879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical and striatal variations in drug competition studies with putative 5-hydroxytryptamine1D binding sites.
    Peroutka SJ
    Brain Res; 1991 Jul; 553(2):206-10. PubMed ID: 1657281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of 5-hydroxytryptamine1D binding sites in sheep caudate nucleus membranes.
    Pauwels PJ; Palmier C; Briley M
    Biochem Pharmacol; 1993 Aug; 46(3):535-8. PubMed ID: 8394085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
    Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS
    Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kainic acid binding in human caudate nucleus: effect of Huntington's disease.
    Henke H
    Neurosci Lett; 1979 Oct; 14(2-3):247-51. PubMed ID: 161000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excitatory amino acid binding sites in the caudate nucleus and frontal cortex of Huntington's disease.
    Dure LS; Young AB; Penney JB
    Ann Neurol; 1991 Dec; 30(6):785-93. PubMed ID: 1665055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of 5-HT1D receptor binding sites in post-mortem human brain cortex.
    Martial J; de Montigny C; Cecyre D; Quirion R
    J Psychiatry Neurosci; 1991 Jul; 16(2):75-80. PubMed ID: 1911737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
    Rothman RB; Cadet JL; Akunne HC; Silverthorn ML; Baumann MH; Carroll FI; Rice KC; de Costa BR; Partilla JS; Wang JB
    J Pharmacol Exp Ther; 1994 Jul; 270(1):296-309. PubMed ID: 8035327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a 5-HT1 recognition site in human brain membranes different from 5-HT1A, 5-HT1B and 5-HT1C sites.
    Hoyer D; Waeber C; Pazos A; Probst A; Palacios JM
    Neurosci Lett; 1988 Mar; 85(3):357-62. PubMed ID: 2966310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin-1 receptor binding sites in the human basal ganglia are decreased in Huntington's chorea but not in Parkinson's disease: a quantitative in vitro autoradiography study.
    Waeber C; Palacios JM
    Neuroscience; 1989; 32(2):337-47. PubMed ID: 2531301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The serotonin 5-HT2C receptor is a prominent serotonin receptor in basal ganglia: evidence from functional studies on serotonin-mediated phosphoinositide hydrolysis.
    Wolf WA; Schutz LJ
    J Neurochem; 1997 Oct; 69(4):1449-58. PubMed ID: 9326273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's disease.
    Cross AJ; Slater P; Reynolds GP
    Neurosci Lett; 1986 Jun; 67(2):198-202. PubMed ID: 2873534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and characterization of the serotonin 5-HT 1D receptor in rat and human brain.
    Herrick-Davis K; Titeler M
    J Neurochem; 1988 May; 50(5):1624-31. PubMed ID: 3361315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of the 5-HT1A receptor and 5-HT1A receptor mRNA in the rat bowel and pancreas: comparison with 5-HT1P receptors.
    Kirchgessner AL; Liu MT; Howard MJ; Gershon MD
    J Comp Neurol; 1993 Jan; 327(2):233-50. PubMed ID: 8425944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.